The Use of M2-Pyruvate Kinase as a Stool Biomarker for Detection of Colorectal Cancer in Tertiary Teaching Hospital: A Comparative Study
Annals of Coloproctology2020Vol. 36(6), pp. 409–414
Citations Over TimeTop 21% of 2020 papers
Shahidah Che Alhadi, Wan Zainira Wan Zain, Zalına Zaharı, Mohd Nizam Md Hashim, Syed Hassan Syed Abd Aziz, Zaıdı Zakarıa, Michael Pak-Kai Wong, Andee Dzulkarnaen Zakaria
Abstract
Fecal M2-PK Quick test has a high sensitivity for detection of colorectal cancer when compared to gFOBT, making it the potential choice for colorectal tumor screening biomarker in the future.
Related Papers
- → Use of colonoscopy for polyp surveillance in Medicare beneficiaries(2013)43 cited
- → Time from Positive Screening Fecal Occult Blood Test to Colonoscopy and Risk of Neoplasia(2008)37 cited
- → Gastroenterologists’ Practice Patterns for Positive Fecal Occult Blood Test(2013)4 cited
- Adenoma Detection on Repeat Colonoscopy after Previous Inadequate Preparation(2013)
- → Fecal Occult Blood Test, Is it still worth for Colorectal Cancer Screening?(2022)1 cited